MM Shores, NL Smith, CW Forsberg… - The Journal of …, 2012 - academic.oup.com
Context: Low testosterone levels in men have been associated with increased mortality. However, the influence of testosterone treatment on mortality in men with low testosterone …
J Hudson, M Cruickshank, R Quinton… - The Lancet Healthy …, 2022 - thelancet.com
Background Testosterone is the standard treatment for male hypogonadism, but there is uncertainty about its cardiovascular safety due to inconsistent findings. We aimed to provide …
RM Haddad, CC Kennedy, SM Caples, MJ Tracz… - Mayo Clinic …, 2007 - Elsevier
OBJECTIVE To conduct a systematic review and meta-analysis of randomized trials that assessed the effect of testosterone use on cardiovascular events and risk factors in men with …
Background Testosterone therapy is increasingly promoted. No randomized placebo- controlled trial has been implemented to assess the effect of testosterone therapy on …
A Qaseem, CA Horwitch, S Vijan… - Annals of internal …, 2020 - acpjournals.org
Description: The American College of Physicians (ACP) developed this guideline to provide clinical recommendations based on the current evidence of the benefits and harms of …
GC Alexander, G Iyer, E Lucas, D Lin… - The American journal of …, 2017 - Elsevier
Purpose We sought to evaluate whether exogenous testosterone therapy is associated with increased risk of serious cardiovascular events as compared with other treatments or …
RC Petering, NA Brooks - American Family Physician, 2017 - aafp.org
Testosterone therapy is increasingly common in the United States, and many of these prescriptions are written by primary care physicians. There is conflicting evidence on the …
ER Mohler III, SS Ellenberg, CE Lewis… - The Journal of …, 2018 - academic.oup.com
Context Studies of the possible cardiovascular risk of testosterone treatment are inconclusive. Objective To determine the effect of testosterone treatment on cardiovascular …
AM Lincoff, S Bhasin, P Flevaris… - … England Journal of …, 2023 - Mass Medical Soc
Background The cardiovascular safety of testosterone-replacement therapy in middle-aged and older men with hypogonadism has not been determined. Methods In a multicenter …